North America Active Pharmaceutical Ingredients Market Report by Drug Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Manufacturer Type (Captive Manufacturers, Merchant API Manufacturers), Synthesis Type (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Therapeutic Application (Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, and Others), and Region 2024-2032

North America Active Pharmaceutical Ingredients Market Report by Drug Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Manufacturer Type (Captive Manufacturers, Merchant API Manufacturers), Synthesis Type (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Therapeutic Application (Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A1521
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Active Pharmaceutical Ingredients Market
    5.1    Market Performance
    5.2    Market Breakup by Drug Type
    5.3    Market Breakup by Manufacturer Type
    5.4    Market Breakup by Synthesis Type
    5.5    Market Breakup by Therapeutic Application
    5.6    Market Breakup by Region 
    5.7    Market Forecast 
6   North America Active Pharmaceutical Ingredients Market
    6.1    Market Performance
    6.2    Impact of COVID-19
    6.3    Market Forecast 
7   North America Active Pharmaceutical Ingredients Market: Breakup by Drug Type 
    7.1    Innovative Active Pharmaceutical Ingredients
    7.2    Generic Active Pharmaceutical Ingredients
8   North America Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type
    8.1    Captive Manufacturers
    8.2    Merchant API Manufacturers
         8.2.1    Innovative Merchant API Manufacturers
         8.2.2    Generic Merchant API Manufacturers
9   North America Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type
    9.1   Synthetic Active Pharmaceutical Ingredients
         9.1.1    Innovative Synthetic APIs
         9.1.2    Generic Synthetic APIs
    9.2   Biotech Active Pharmaceutical Ingredients
         9.2.1    Innovative Biotech APIs
         9.2.2    Biosimilars
10   North America Biotech Active Pharmaceutical Ingredients Market: Breakup by Product and Expression System Type
    10.1   Product Type
         10.1.1    Monoclonal Antibodies
         10.1.2    Vaccines
         10.1.3    Cytokines
         10.1.4    Others
    10.2   Expression System Type
         10.2.1    Mammalian Expression System
         10.2.2    Microbial Expression System
         10.2.3    Yeast Expression System
         10.2.4    Others
11  North America Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application
    11.1   Oncology
    11.2   Cardiovascular and Respiratory
    11.3   Diabetes
    11.4   Central Nervous System Disorders
    11.5   Neurological Disorders
    11.6   Others
12  North America Active Pharmaceutical Ingredients Market: Breakup by Country 
    12.1   United States
         12.1.1    Historical Market Trends
         12.1.2    Market Breakup by Drug Type
         12.1.3    Market Breakup by Manufacturer Type
         12.1.4    Market Breakup by Synthesis Type
         12.1.5    Biotech API Market Breakup by Product Type
         12.1.6    Biotech API Market Breakup by Expression System Type
         12.1.7    Market Breakup by Therapeutic Application
         12.1.8    Market Forecast
    12.2   Canada
         12.2.1    Historical Market Trends
         12.2.2    Market Breakup by Drug Type
         12.2.3    Market Breakup by Manufacturer Type
         12.2.4    Market Breakup by Synthesis Type
         12.2.5    Biotech API Market Breakup by Product Type
         12.2.6    Biotech API Market Breakup by Expression System Type
         12.2.7    Market Breakup by Therapeutic Application
         12.2.8    Market Forecast
    12.3   Mexico
         12.3.1    Historical Market Trends
         12.3.2    Market Breakup by Drug Type
         12.3.3    Market Breakup by Manufacturer Type
         12.3.4    Market Breakup by Synthesis Type
         12.3.5    Biotech API Market Breakup by Product Type
         12.3.6    Biotech API Market Breakup by Expression System Type
         12.3.7    Market Breakup by Therapeutic Application
         12.3.8    Market Forecast
13  SWOT Analysis 
    13.1    Overview 
    13.2    Strengths
    13.3    Weaknesses 
    13.4    Opportunities
    13.5    Threats
14  Value Chain Analysis 
15  Porter’s Five Forces Analysis 

    15.1     Overview
    15.2     Bargaining Power of Buyers
    15.3     Bargaining Power of Suppliers
    15.4     Degree of Rivalry
    15.5     Threat of New Entrants
    15.6     Threat of Substitutes
16  Price Analysis 
17  Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players

List of Figures

Figure 1: North America: Active Pharmaceutical Ingredients Market: Major Drivers and Challenges
Figure 2: Global: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2023
Figure 4: Global: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2023
Figure 5: Global: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2023
Figure 6: Global: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2023
Figure 7: Global: Active Pharmaceutical Ingredients Market: Breakup by Region (in %), 2023
Figure 8: Global: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: North America: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2018-2023
Figure 10: North America: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 11: North America: Active Pharmaceutical Ingredients Industry: SWOT Analysis
Figure 12: North America: Active Pharmaceutical Ingredients Industry: Value Chain Analysis
Figure 13: North America: Active Pharmaceutical Ingredients Industry: Porter’s Five Forces Analysis
Figure 14: North America: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2023
Figure 15: North America: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 16: North America: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 17: North America: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 18: North America: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 19: North America: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2023
Figure 20: North America: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 21: North America: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 22: North America: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 23: North America: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 24: North America: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2023
Figure 25: North America: Active Pharmaceutical Ingredients (Synthetic Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 26: North America: Active Pharmaceutical Ingredients (Synthetic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 27: North America: Active Pharmaceutical Ingredients (Biotech Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 28: North America: Active Pharmaceutical Ingredients (Biotech Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 29: North America: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2023
Figure 30: North America: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 31: North America: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 32: North America: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 33: North America: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 34: North America: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 35: North America: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 36: North America: Biotech Active Pharmaceutical Ingredients (Other Product Types) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 37: North America: Biotech Active Pharmaceutical Ingredients (Other Product Types) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 38: North America: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2023
Figure 39: North America: Biotech Active Pharmaceutical Ingredients (Mammalian Expression System) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 40: North America: Biotech Active Pharmaceutical Ingredients (Mammalian Expression System) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 41: North America: Biotech Active Pharmaceutical Ingredients (Microbial Expression System) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 42: North America: Biotech Active Pharmaceutical Ingredients (Microbial Expression System) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 43: North America: Biotech Active Pharmaceutical Ingredients (Yeast Expression System) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 44: North America: Biotech Active Pharmaceutical Ingredients (Yeast Expression System) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 45: North America: Biotech Active Pharmaceutical Ingredients (Other Expression System Types) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 46: North America: Biotech Active Pharmaceutical Ingredients (Other Expression System Types) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 47: North America: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2023
Figure 48: North America: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 49: North America: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 50: North America: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 51: North America: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 52: North America: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 53: North America: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 54: North America: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 55: North America: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 56: North America: Active Pharmaceutical Ingredients (Neurological Disorders) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 57: North America: Active Pharmaceutical Ingredients (Neurological Disorders) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 58: North America: Active Pharmaceutical Ingredients (Other Therapeutic Applications) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 59: North America: Active Pharmaceutical Ingredients (Other Therapeutic Applications) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 60: United States: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2018-2023
Figure 61: United States: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2023
Figure 62: United States: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2023
Figure 63: United States: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2023
Figure 64: United States: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2023
Figure 65: United States: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2023
Figure 66: United States: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2023
Figure 67: United States: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 68: Canada: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2018-2023
Figure 69: Canada: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2023
Figure 70: Canada: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2023
Figure 71: Canada: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2023
Figure 72: Canada: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2023
Figure 73: Canada: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2023
Figure 74: Canada: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2023
Figure 75: Canada: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 76: Mexico: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2018-2023
Figure 77: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2023
Figure 78: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2023
Figure 79: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2023
Figure 80: Mexico: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2023
Figure 81: Mexico: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2023
Figure 82: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2023
Figure 83: Mexico: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2024-2032

List of Tables

Table 1: North America: Active Pharmaceutical Ingredients Market: Key Industry Highlights, 2023 and 2032
Table 2: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Drug Type (in Billion US$), 2024-2032
Table 3: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Manufacturer Type (in Billion US$), 2024-2032
Table 4: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Synthesis Type (in Billion US$), 2024-2032
Table 5: North America: Biotech Active Pharmaceutical Ingredients Market Forecast: Breakup by Product Type (in Billion US$), 2024-2032
Table 6: North America: Biotech Active Pharmaceutical Ingredients Market Forecast: Breakup by Expression System Type (in Billion US$), 2024-2032
Table 7: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Therapeutic Application (in Billion US$), 2024-2032
Table 8: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (in Billion US$), 2024-2032
Table 9: North America: Active Pharmaceutical Ingredients Market: Competitive Structure
Table 10: North America: Active Pharmaceutical Ingredients Market: Key Players

North America Active Pharmaceutical Ingredients Market Report by Drug Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Manufacturer Type (Captive Manufacturers, Merchant API Manufacturers), Synthesis Type (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Therapeutic Application (Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More